Personalis, Inc. (PSNL)

Name: Personalis, Inc. (PSNL) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001527753 · Nasdaq · Services-Medical Laboratories

Sector Services
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Personalis, Inc. reported revenue of $69.65M. Revenue fell 17.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $69.67M.

Key ratios (year ended 2025-12-31)

22.7%

Gross margin (computed)

-126.4%

Operating margin

-116.7%

Net margin

-31.1%

Return on year-end equity

-17.7%

Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-06

Headquarters locality: Menlo Park · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Revenue	$69.67M	$69.65M	$84.61M	$73.48M	$65.05M	$85.49M	$78.65M	$65.21M	$37.77M	$9.39M
Cost of Revenue	$60.83M	$53.87M	$57.79M	$55.27M	$51.70M	$53.84M	$58.53M	$43.13M	$25.97M	$11.74M
Gross Profit (computed)	$8.84M	$15.78M	$26.82M	$18.21M	$13.35M	$31.66M	$20.11M	$22.08M	$11.80M	-$2.34M
R&D Expense	$56.12M	$50.26M	$48.91M	$64.78M	$64.91M	$49.31M	$28.57M	$22.42M	$14.30M	$9.92M
Operating Income	-$114.31M	-$88.06M	-$68.27M	-$109.94M	-$115.53M	-$65.35M	-$42.15M	-$22.42M	-$13.77M	-$22.16M
Depreciation & Amortization	$9.71M	$10.05M	$10.94M	$11.30M	$8.43M	$6.01M	$5.76M	$4.75M	$3.07M	$1.22M
EBITDA	-$104.60M	-$78.01M	-$57.33M	-$98.64M	-$107.10M	-$59.34M	-$36.39M	-$17.67M	-$10.70M	-$20.95M
Net Income	-$107.18M	-$81.27M	-$81.28M	-$108.30M	-$113.31M	-$65.23M	-$41.28M	-$25.08M	-$19.89M	-$23.60M
EPS (Diluted)	n/a	-$0.91	-$1.37	-$2.25	-$2.48	-$1.49	-$1.20	n/a	n/a	n/a
Total Assets	$312.13M	$334.16M	$270.27M	$225.10M	$292.70M	$396.53M	$244.84M	$157.29M	$41.67M	n/a
Total Liabilities	$76.97M	$72.98M	$67.31M	$95.66M	$74.56M	$86.23M	$49.90M	$50.60M	$58.65M	n/a
Shareholders' Equity	$235.16M	$261.19M	$202.96M	$129.44M	$218.14M	$310.30M	$194.94M	$106.69M	-$106.39M	-$92.60M
Cash & Equivalents	$93.97M	$124.25M	$91.42M	$56.98M	$89.13M	$105.58M	$68.53M	$55.05M	$19.74M	n/a
Operating Cash Flow	-$92.30M	-$74.95M	-$45.15M	-$56.26M	-$70.23M	-$70.83M	-$42.65M	-$18.07M	$5.57M	$290.0K
Capital Expenditures	$8.68M	$4.50M	$1.60M	$10.91M	$49.90M	$11.08M	$3.25M	$8.38M	$7.85M	$5.16M
Free Cash Flow	-$100.97M	-$79.45M	-$46.75M	-$67.17M	-$120.13M	-$81.91M	-$45.90M	-$26.45M	-$2.28M	-$4.87M
Shares Outstanding	106.37M	102.48M	85.17M	50.48M	46.71M	44.90M	39.11M	31.24M	3.09M	n/a
Weighted Average Diluted Shares	n/a	89.24M	59.25M	48.18M	45.70M	43.89M	34.37M	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.91	-$1.37	-$2.25	-$2.48	-$1.49	-$1.20	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView